EVOLOCUMAB
evolocumab 140 mg/mL injection, 1 mL pen device
EVOLOCUMAB (11985T)
11985T
Body System:
Manner of administration:Injection
Restriction (Streamlined authority code: 16336)
Indication: Non-familial hypercholesterolaemia
Treatment phase: Continuing treatment with this drug or switching treatment from any of: (i) another
drug that belongs to the same pharmacological class as this drug, (ii) inclisiran
Restriction (Streamlined authority code: 16350)
Indication: Familial heterozygous hypercholesterolaemia
Treatment phase: Continuing treatment with this drug or switching treatment from any of: (i) another
drug that belongs to the same pharmacological class as this drug, (ii) inclisiran
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $437.80 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Repatha | |||||